In a new poll conducted for TheraPsil, Pollara Strategic Insights has discovered that 64% of Canadians express top-of-mind acceptance (41% approve, 23% are ambivalent) of “the federal government legalizing psilocybin mushrooms for medicinal use by people who are suffering from a terminal illness, such as terminal cancer”. Moreover, after provided information about psilocybin clinical trials amongst patients with depression or a terminally ill condition, acceptance rises to 78% (59% approve, 19% are ambivalent).
Share this post
